Individual isotoxic radiation dose escalation based on V20 and advanced technologies benefits unresectable stage III non-small cell lung cancer patients treated with concurrent chemoradiotherapy: long term follow-up

Under the assumption that the highest therapeutic ratio could be achieved by increasing the total tumor dose (TTD) to the limits of normal tissues, the phase I trial was conducted in patients with unresectable stage III non-small cell lung cancer treated with concurrent chemoradiotherapy, to determi...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncotarget
Huvudupphovsmän: Liu, Ming, Wang, Zhongtang, Zhou, Tao, Zhou, Antang, Zhao, Qian, Li, Hongsheng, Sun, Hongfu, Huang, Wei, Li, BaoSheng
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2017
Ämnen:
Clinical Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5584295/
https://ncbi.nlm.nih.gov/pubmed/28881694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16288
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk